Core & Trust
Conflicts of Interest Policy
Every relationship that could bias a page
A conflict of interest is any tie that could pull a page away from the evidence. Tirzepatide Ranked is affiliate-supported, which is a standing interest; we handle it with a published methodology, dated prices and a public corrections log. Contributors declare their own ties, and we publish what we find.
Contributors may not take payment from a provider we cover; the site itself is affiliate-supported, as the disclosure page explains. If that ever changes, the relationship is disclosed on every affected page and the person is removed from the affected coverage.
Show this figure as a table
| Step | Stage | What happens |
|---|---|---|
| 1 | Someone raises it | A reader, a provider or an editor flags the issue. |
| 2 | It is assessed against the ledger | We reopen the source and the capture date. |
| 3 | A decision is recorded | Correct, clarify, or explain why the original stands. |
| 4 | The change is published and dated | Old figures stay visible in the log. |
| Area | Commitment | How you can check it |
|---|---|---|
| Every figure | Carries a source and a capture date | Open the provenance stamp beside it |
| Every clinical claim | Traced to a primary source | Follow the citation, not our summary |
| Every score | Computed from published inputs | Read the raw inputs on the provider page |
| Every correction | Dated and permanent | Read the corrections log |
| Every medical review | Dated on the page | Read “Last medically reviewed” in the byline |
A dash means no figure held. How we grade evidence.
What this policy covers
A conflict of interest is anything that gives the person writing, scoring or reviewing a page a reason to want a particular answer. This policy covers three kinds:
- The site's own. Tirzepatide Ranked is affiliate-supported and may earn a commission when you enroll through a link here. That is a standing interest. The affiliate and commercial disclosure sets out how it is kept away from scores and prices.
- Contributors'. Employment, consulting, ownership or paid work for a company in the GLP-1 market, including telehealth programs, pharmacies, manufacturers and competing review sites.
- Clinical reviewers'. Clinicians who medically review pages may also practise elsewhere. Their outside roles matter when a page covers a company they work for or with.
It applies to every page that names a provider, a pharmacy, a manufacturer or a price.
How we apply it
- A check before publication. The conflict check is one of the thirteen gates in our editorial standards. The editor responsible for the page asks whether anyone who wrote, scored or reviewed it has a tie to a company it covers.
- Clinicians are checked too. No clinician reviews a page about a company they work for, consult to or hold an interest in. Their outside roles are checked against the companies on the page before their review credit appears.
- Conflicted people step off. A contributor with a tie to a company does not write, score or review coverage of it. Someone else repeats their step.
- The site's interest is handled by method. Scores follow the published v4.1 rubric, prices carry the date they were read, and the inputs are shown on each provider page. Whether a link is commissionable is not a scoring input.
- Missed checks are logged. If a conflict is found after publication, the finding and the fix go on the corrections log with a date.
How to hold us to it
If you know of a tie we have not disclosed, tell us through the contact page. It might be between a contributor, a reviewer or the site and a company we cover. Name the person or page and, if you can, the public source that shows the relationship.
We check it against the public record. If the tie is real and relevant, the affected pages are re-reviewed by someone without it, and the finding is logged on the corrections log with a date. If we decide it is not relevant, we explain why.
We have not published a fixed response time. Each logged correction shows its date, so you can see how we have handled past findings.
Providers who believe a conflict has affected their score can also use the right to respond.
Medical reviewer credit: suspended in July, restored in November
On 26 July 2026 this site suspended the medical-reviewer credit for Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC), after finding both named on RxPepsDirect’s pages as its medical director and prescribers. That finding is still on the record as COR-006.
From the November 9, 2026 update the publisher has restored the credit: Dr. Snipes and Kim Callender review each site update, and every page they reviewed shows “Last medically reviewed” with the date of that review. The change is logged as COR-012. If you think a reviewer’s other work has affected a page, tell us through the contact page and we will look at that page again.
Related on this site
- Tirzepatide Ranked: Evidence, Prices, Providers & ToolsCore & Trust
- About Tirzepatide RankedCore & Trust
- Editorial StandardsCore & Trust
- Provider Ranking MethodologyCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Provider Right to RespondCore & Trust
- AI Use PolicyCore & Trust
- Terms of UseCore & Trust
- Methodology and Dataset ChangelogData
Related coverage
- Compounded Tirzepatide Online: Legal, Safety and Cost Guide
- Compounded tirzepatide price index
- What you pay at a maintenance dose
- GLP-1s and Vision: Two Different Issues That Get Conflated
- What a GLP-1 Actually Costs Over a Year, and Over Five
- GLP-1 Drug Interactions: The Three That Change Management
- Flat-Rate GLP-1 Pricing: What It Means and When It Saves Money
- Hitting a Plateau on a GLP-1: What the Evidence Says
- GLP-1 Programs With No Membership Fee (2026)
Tirzepatide Ranked. “Conflicts of Interest Policy.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/conflicts-of-interest/
Quote the capture date beside a figure, not the date you read this page. Why.